Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells

Cryo-Save introduces unique service for the U.S. people to store adipose-derived stem cells

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

Researchers identify five SNPs linked with aggressive, lethal prostate cancer

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Nearly half of men expect better recovery from side-effects of prostate cancer surgery

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan receives positive opinion from Irish Medicines Board for BOTOX

A guide to safe and informed recovery after prostate cancer

A guide to safe and informed recovery after prostate cancer

Three flutemetamol clinical abstracts to be presented at 2011 Alzheimer's Association ICAD

Three flutemetamol clinical abstracts to be presented at 2011 Alzheimer's Association ICAD

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

Transvaginal placement of surgical mesh for pelvic organ prolapse may pose greater risk, warns FDA

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada

Urinary incontinence after child birth increases risk of postpartum depression

Urinary incontinence after child birth increases risk of postpartum depression

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

Prior GID diagnosis impacts health outcomes of patients with Parkinson's

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

Wireless near-infrared spectroscopy can effectively detect bladder disease in children

UK's NICE issues guidance on PTNS treatment for faecal incontinence

UK's NICE issues guidance on PTNS treatment for faecal incontinence

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Positive results from Astellas Pharma's mirabegron phase III trial in overactive bladder

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification

Caldera's Desara Mini implant for Stress Urinary Incontinence receives CE Mark certification